Grants for Small businesses - Science and Technology

The FY24 LCRP Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. Research applications only in the area of mesothelioma will not be accepted. This award is intended to support impactful research projects with an emphasis on discovery.Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.Key elements of this award are as follows:Principal Investigator (PI): PIs must be research- or physician-scientists at an early stage of their independent research careers. PIs must be within 5 years of their first faculty appointment (or equivalent) and exhibit a strong desire to pursue a career in lung cancer research.Mentorship: The Mentor(s) must be an experienced lung cancer researcher(s) as demonstrated by a strong record of funding and publications in lung cancer research. In addition, the Mentor(s) must demonstrate a commitment to developing the PIs career in lung cancer research.Career Development: A Career Development Plan is required and should be prepared with appropriate guidance from the Mentor(s). A clearly articulated strategy for acquiring the necessary skills, competence, and expertise to have a career at the forefront of lung cancer research should be included. The plan should outline how the PI will gain experience in lung cancer research. Because career development is the focus of this award, the PI must commit a minimum of a 25% level of time and effort during the period of performance to conduct lung cancer research under this award.Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths and suffering from lung cancer.Relevance to Military Health System (MHS) Beneficiaries: The application should clearly articulate how the proposed research is relevant to Service Members, Veterans, and their Families.The PI is required to attend a Department of Defense (DOD) one day in progress review meeting prior to the end of the second year of the award.

The ERP seeks to solicit Faculty members to join the Virtual Post-Traumatic Epilepsy Research Center (P-TERC) in order to advance PTE research through development of early-career investigators and investigators new to the PTE field. The ERP Virtual P-TERC is a unique, interactive virtual research center providing intensive mentoring, national networking, collaborations, and a peer group for new PTE investigators. The overarching goal of the Virtual P-TERC is to develop successful, highly productive PTE researchers in a collaborative research and career development environment to enhance quality and expand quantity of the PTE research field. The Virtual P-TERC is a multi-institutional career development and research training platform that consists of Faculty and their Career Guides (primary mentors) and is managed by a Director and Deputy Director. The Virtual P-TERC Leadership (the Director and the Deputy Director) serve as a resource for the Faculty and Career Guides, assessing the progress of Faculty and facilitating communication and collaboration among all of the Faculty and Career Guides, as well as with national research societies and representatives from the community with lived PTE experience. In addition to fostering scientific development, the Virtual P-TERC, through its Leadership, provides for professional and leadership development of the Faculty to include skills and competencies needed to fund and manage a productive PTE research laboratory.

The Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development (RAMPS) Program seeks to build multistakeholder workforce partnerships of employers, schools and institutions of higher education, and other community organizations. Effective multistakeholder workforce partnerships will organize multiple employers with skill shortages in specific occupations to focus on developing the skilled workforce to meet industry needs within the local or regional economy.

The FY24 Transformative Breast Cancer Consortium Development Award is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award (pending availability of funds). This is a development award and is a separate mechanism from the full consortium award. Recipients of the FY24 Transformative Breast Cancer Consortium Development Award are expected to submit an application to compete for the full Transformative Breast Cancer Consortium Award anticipated to be offered in a future fiscal year(s). However, it is not necessary to receive a development award in order to apply for a full consortium award in the future. For FY24, investigators may be named as Consortium Director on an application submitted to either (but not both) of these mechanisms. Detailed information on the FY24 Transformative Breast Cancer Consortium Award is available under a separate program announcement (HT942524BCRPTBCCA).The FY24 Transformative Breast Cancer Consortium Development Award provides support to: Develop the infrastructure of a multi-institutional research team inclusive of scientists, clinicians, and breast cancer advocates (e.g., building appropriate collaborations, outlining integration, research management, administrative management, and communication plans, and devising an intellectual property plan) Generate necessary preliminary data to serve as proof of concept or for project integration Acquire research resources Develop a framework of necessary statistical analysesBreast cancer consumer advocates must be active participants in the development and execution of the Transformative Breast Cancer Consortium Development Award.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Research involving human subjects and research involving human anatomical substances and data is permitted; however, clinical trials are not allowed under this funding opportunity.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 BCRP Transformative Breast Cancer Consortium Development Award should not exceed $100,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $0.16M to fund approximately one Transformative Breast Cancer Consortium Development Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding initiative provides financial support and business expertise to early-stage life science and biotechnology companies in Pennsylvania to foster innovation and job creation in the industry.

This program provides financial support to nonprofit arts and culture organizations, local arts districts, and individual professionals in Pennsylvania to help them recover and stabilize after the impacts of the COVID-19 pandemic.

This program provides financial support to eligible Pennsylvania companies for employee training in key industries to enhance workforce skills and improve business competitiveness.

This program provides free technical assistance to small Pennsylvania businesses to help them improve their operations and competitiveness by connecting them with expert resources and solutions for specific technical challenges.

This funding is aimed at fostering collaboration among regional economic development organizations to improve services for businesses and create a more effective statewide economic strategy.

This program provides financial assistance ranging from $5,000 to $50,000 to small businesses in Pennsylvania that have been adversely affected by the COVID-19 pandemic.

This program provides $200 million in competitive funding to improve broadband access in underserved areas lacking reliable internet service of at least 25/3 Mbps.

To obtain a copy of the Funding Opportunity Announcement (FOA) please go to the ARPA-E website at https://arpa-e-foa.energy.gov. To apply to this FOA, Applicants must register with and submit application materials through ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov/Registration.aspx). For detailed guidance on using ARPA-E eXCHANGE, please refer to the ARPA-E eXCHANGE User Guide (https://arpa-e-foa.energy.gov/Manuals.aspx). ARPA-E will not review or consider concept papers submitted through other means. For problems with ARPA-E eXCHANGE, email [email protected] (with FOA name and number in the subject line). Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email [email protected]. To read this FOA in its entirety, please go to the ARPA-E website at https://arpa-e-foa.energy.gov. Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email [email protected]. The purpose of this modification is to incorporate changes to Funding Opportunity Announcement. Accordingly, this modification, Inserted new Exploratory Topic, Topic L: Plant HYperaccumulators TO MIne Nickel-Enriched Soils (PHYTOMINES). See Table 1. Exploratory Topics, Appendix L, and Total Amounts to be awarded on Cover Page.

This program provides essential financial support to small businesses in Pennsylvania that have been negatively affected by the COVID-19 pandemic, helping them access working capital to sustain their operations.

This grant supports entrepreneurs and researchers in Pennsylvania by providing resources and funding to help turn innovative ideas into marketable products and services that benefit the community and beyond.

The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs Financial Info: The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs

The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage Financial Info: The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage

The Advanced Industries Early-Stage Capital and Retention Grant aims to support Colorado-based advanced industries technology businesses in developing and commercializing new technologies that will be created or manufactured in the state. The grant addresses the market's underinvestment in early-stage technologies by offering financial support of up to $250,000, with the possibility of exceeding this amount for projects impacting multiple advanced industries. Eligible businesses must be involved in creating disruptive technology, be registered and in good standing with the Colorado Secretary of State, have a significant presence in Colorado, provide a 2-to-1 non-State funding match, and have limited prior financial support and revenues. Preference is given to applicants with ties to Colorado research institutions, entrepreneurship programs, and those recognized by investment groups for their commercial potential. Applications are accepted biannually Grant renewed every year. Grant Summer Annual deadline: July to September

The Advanced Industries Early-Stage Capital and Retention Grant aims to support Colorado-based advanced industries technology businesses in developing and commercializing new technologies that will be created or manufactured in the state. The grant addresses the market's underinvestment in early-stage technologies by offering financial support of up to $250,000, with the possibility of exceeding this amount for projects impacting multiple advanced industries. Eligible businesses must be involved in creating disruptive technology, be registered and in good standing with the Colorado Secretary of State, have a significant presence in Colorado, provide a 2-to-1 non-State funding match, and have limited prior financial support and revenues. Preference is given to applicants with ties to Colorado research institutions, entrepreneurship programs, and those recognized by investment groups for their commercial potential. Applications are accepted biannually. Grant renewed every year. Grant Winter Annual deadline: January to March

The Florida Online Global-Website Localization Grant aims to help exporters expand their overseas presence through website localization services. The program, in partnership with IBT Online and SelectFlorida, offers various options for website globalization, including predefined and customized websites, website redesign, and e-commerce development, all optimized for target markets. Grants cover partial costs of localization services, with SelectFlorida covering up to $8,000 and the grantee responsible for $4,000 or the balance for customized services. Eligible entities must meet specific qualifications including being Florida-based, meeting minimum sales and employment criteria, and operating in approved sectors.

This program provides financial assistance to businesses and local governments for environmental assessments and cleanup efforts at former industrial sites, promoting the revitalization of contaminated land for productive use.